Showing results (61-70 of 1,244) with videos related to

Sort By:
Pageof 125
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney diseaseOshini Shivakumar, Naveed Sattar, David C Wheeler
Diabetes Care|July 2, 2008
Metabolic syndrome and incident diabetes: current state of the evidenceEarl S Ford, Chaoyang Li, Naveed Sattar
The Lancet. Diabetes & Endocrinology|May 18, 2019
Understanding the mechanisms of reversal of type 2 diabetesRoy Taylor, Ahmad Al-Mrabeh, Naveed Sattar
Joint Bone Spine|May 2, 2025
Weighing in on Obesity and Psoriatic Arthritis - Time to move beyond association to robust randomised trialsStefan Siebert, Naveed Sattar, Lyn D Ferguson
JAMA Cardiology|August 4, 2016
Association of Lipid Fractions With Risks for Coronary Artery Disease and DiabetesJon White, Daniel I Swerdlow, David Preiss, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
Arthritis Research & Therapy|March 4, 2005
Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?David W McCarey, Naveed Sattar, Iain B McInnes
Human Reproduction (Oxford, England)|September 25, 2004
Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements?Sabine Muth, Jane Norman, Naveed Sattar, et al.
Nature Medicine|March 11, 2020
Improving prevention strategies for cardiometabolic diseaseNaveed Sattar, Jason M R Gill, William Alazawi
Annals of the Rheumatic Diseases|May 30, 2013
Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactionsHanna Johnsson, Maurizio Panarelli, Allan Cameron, et al.
Pageof 125